Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Drug Notebook

Generic Name: ethinyl estradiol-norgestimate

View All Brands
Ortho Tri-Cyclen Lo, Ortho-Cyclen, Sprintec, Tri-Previfem, TriNessa, Previfem, Tri-Sprintec, Ortho Tri-Cyclen, Mononessa
a sex hormone combination
Search Drug Notebook
Hide
Your search results:
Search the ethinyl estradiol-norgestimate Drug Notebook
FDA Alerts

  • Cigarette smoking during oral contraceptive use increases the risk of serious adverse cardiovascular effects. This risk increases with age and with heavy smoking (≥15 cigarettes daily) and is markedly greater in women >35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.

Drug Info Tools
Search by color, shape and markings. click here
Check any 2 drugs for interactions. click here
Compare any two drugs side by side. click here
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Licensed from
ethinyl estradiol-norgestimate
What is the price of this medication and similar alternatives?Who should NOT use this medication?Where can I get more information?

What is the price of this medication and similar alternatives?

This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 09/2009. For the most current and up-to-date pricing information, please visit www.drugstore.com. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.

Femhrt 1/5 1-5MG-MCG Tablets WARNER CHILCOTT PROF PROD DIV30/$70.65 or 90/$186.9
Femhrt Low Dose 0.5-2.5MG-MCG Tablets WARNER CHILCOTT PROF PROD DIV30/$72.02 or 90/$193.46
Ortho Evra 150-20MCG/24HR Patches ORTHO-MCNEIL PHARMACEUTICAL3/$69.22 or 9/$179.82

Back to Top

Who should NOT use this medication?

  • Hypersensitivity to the drug or any ingredient in the formulation.
  • Known or suspected pregnancy.
  • Undiagnosed abnormal genital bleeding.
  • Diplopia or any ocular lesion arising from ophthalmic vascular disease.
  • Classical migraine.
  • Active liver disease or history of cholestatic jaundice with pregnancy or with prior use of oral contraceptives.
  • Breast-feeding.
  • Thrombophlebitis or thromboembolic disorders.
  • Cerebrovascular disease or CAD (including MI).
  • Severe hypertension.
  • Diabetes with vascular involvement.
  • Known or suspected carcinoma of the breast.
  • Known or suspected estrogen-dependent neoplasia (e.g., carcinoma of the endometrium).
  • Benign or malignant liver tumor that developed during oral contraceptive or other estrogen use.
  • Oral contraceptives containing the progestin drospirenone are contraindicated in women with renal or hepatic impairment and in those with adrenal insufficiency.
  • Most experts state that there currently is no real contraindication to postcoital (emergency) contraception with the recommended regimens and that the benefits generally outweigh any theoretical or proven risk.

Back to Top

Where can I get more information?
More Information

Back to Top

Back to Top